Karuna Therapeutics 10K Form
7 Day Trial
ALL ACCESS PASS
10K form not available
Receive KRTX News And Ratings
See the #1 stock for the next 7 days that we like better than KRTX
KRTX Financial Statistics
Sales & Book Value
|Price / Cash Flow:||0|
|Price / Book:||5.65|
|Net Income (TTM):||$-276.34M|
|Return on Equity:||-37.64%|
|Return on Assets:||-36.1%|
Karuna Therapeutics Earnings Forecast
Key Karuna Therapeutics Financial Ratios
- The Research & Development expenses have been 2,107.61% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of KRTX is -2,597.18% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Karuna Therapeutics Stock Price Chart
Industry, Sector and Symbol
|Trailing P/E Ratio:||0|
|Forward P/E Ratio:||0|
KRTX Technical Analysis vs Fundamental Analysis
Karuna Therapeutics (KRTX) is a Buy
Is Karuna Therapeutics a Buy or a Sell?
Karuna Therapeutics stock is rated a Buy
The current Karuna Therapeutics [KRTX] share price is $182.42. The Score for KRTX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.